Myriad Genetics Inc (MYGN): Depreciation & Amortization
$53.70M
Year ended 2025-12-31
$50.20M
Trailing 12 months to 2026-06-30
+0.6%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $53.70M | -12.3% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $61.20M | -1.1% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $61.90M | +17.5% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $52.70M | -16.1% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $62.80M | n/a | 2024-02-28, From 2021-01-01 |
| No annual figure between 2020-06-30 and 2021-12-31. | |||
| 2020-06-30 | $72.00M | -1.4% | 2023-03-01, From 2019-07-01 |
| 2019-06-30 | $73.00M | +34.2% | 2022-02-25, From 2018-07-01 |
| 2018-06-30 | $54.40M | +12.6% | 2020-08-13, From 2017-07-01 |
| 2017-06-30 | $48.30M | +80.2% | 2019-08-13, From 2016-07-01 |
| 2016-06-30 | $26.80M | +7.2% | 2018-08-24, From 2015-07-01 |
| 2015-06-30 | $25.00M | +81.2% | 2017-08-09, From 2014-07-01 |
| 2014-06-30 | $13.80M | +55.1% | 2016-08-10, From 2013-07-01 |
| 2013-06-30 | $8.90M | -1.9% | 2015-08-12, From 2012-07-01 |
| 2012-06-30 | $9.07M | +25.6% | 2014-08-13, From 2011-07-01 |
| 2011-06-30 | $7.22M | +1.9% | 2013-08-14, From 2010-07-01 |
| 2010-06-30 | $7.08M | -25.0% | 2012-08-15, From 2009-07-01 |
| 2009-06-30 | $9.45M | n/a | 2011-08-15, From 2008-07-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $53.70M | -12.3% |
| Neogen Corp (NEOG) | 2026-05-31 | $116.30M | -2.7% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $70.10M | +8.5% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $442.00M | -2.5% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $145.18M | +11.7% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $9.77M | -5.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $6.34M | -3.6% |
| Immucell Corp (ICCC) | 2025-12-31 | $2.78M | +2.0% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $112.0K | +21.7% |
Compare MYGN, NEOG, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗